Global Biodefense August 5, 2019
When Project BioShield was initially signed into law 15 years ago, the nation had few medical countermeasures to rely on in national emergencies. BARDA has since supported 27 projects using Project BioShield authorities and funding, adding 15 products to the Strategic National Stockpile. Working with industry partners, 10 of those products have achieved FDA approval and the others are available under FDA Emergency Use Authorization guidelines. Companies interested in partnering with BARDA on medical countermeasures to combat chemical, biological, radiological, or nuclear (CBRN) threats, pandemic influenza or other emerging infectious diseases, can get insights and strategic advice from HHS/ASPR Biomedical Advanced Research and Development Authority (BARDA) at a TechWatch BARDA awards advanced research and development funds based on proposals submitted under a rolling BARDA Broad Agency Announcement…read more.